Back to search results

Goal Setting to Promote Physical Activity in Midlife Adults

This study is looking at different ways to help adults aged 45 to 65 increase their physical activity. The intervention being tested is a "theory-driven behavioral physical activity promotion intervention," which means it uses specific methods to encourage more movement. The goal is to find the best goal-setting techniques to help people stick to national physical activity guidelines, which could reduce the risk of Alzheimer's disease and related dementias (AD/ADRD). Researchers will measure changes in your physical activity using devices like accelerometers and Fitbits, and through self-reported questionnaires, over 6 and 9 months. You might be eligible if you are between 45 and 65, have a BMI (Body Mass Index) between 30 and 50, weigh at least 110 pounds, and currently get 60 minutes or less of moderate-to-vigorous physical activity per week. You also need a smartphone (iOS or Android). The current status of this study is unclear, but it plans to enroll 144 participants.

Study design
This is an interventional study planning to enroll 144 participants. It will test three different goal-setting techniques to promote physical activity.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for changes in physical activity up to 9 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05980052

Goal Setting to Promote Physical Activity Adherence in Midlife Adults

Recruiting
NAAges 45–65InterventionalPrevention
Arizona State University
~144 participants
Updated 2026-07-17 on ClinicalTrials.gov
What's tested:Physical Activity

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in accelerometer-measured moderate-to-vigorous intensity physical activity from baseline to 6- and 9-months
Measured over Assessed at baseline, 6-months, 9-months
+2 more outcomes measured

Conditions

Physical Activity
Exercise

Explore related trials

Alzheimer's DiseaseDementiaMild cognitive disorder

Where it's being run

1 sites across 1 states
Arizona1

Who to contact

Rodney Joseph, PhD
[email protected]
602-496-0772
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Aged 45 to 65 years
BMI between 30 kg/m2 to 50 kg/m2
Participants must weigh a minimum of 110 pounds
Engaging in 60 minutes or less of self-reported moderate-to-vigorous physical activity at screening (based on Exercise Vital Sign Questionnaire)
Self-reported ownership of a smartphone with an iOS or Android operating system (necessary for participants to track their activity using a Fitbit activity monitor)

Exclusion

Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a physician's note is provided
Resting blood pressure greater than 200/110 mmHG as assessed at the baseline study assessment (unless a physician's note is provided)
Pregnant or planning to become pregnant in next 8-months (Phase 1) or 12 months (Phase 2)
Plans to relocate out of metropolitan Phoenix, Arizona area in the next 8-months (Phase 1) or 12 months (Phase 2)
Participation in another physical activity, nutrition or weight loss program at time of screening or at any time during the intervention
Individuals with mild cognitive impairment (MCI), as determined by either a self-report of receiving a diagnosis of MCI from a health care provider or as assessed by the Montreal Cognitive Assessment (MoCA) at the study orientation session. A score \< 26 is an exclusion criterion for US born participants. A score of \<23 is an exclusion for participants born outside of the US who completed their high school education in a country where English is not the primary language.
Being previously prescribed one of the 5 approved Alzheimer's medications, including: Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Razadyne), Memantine (Namenda), Memantine + Donepezil (Namzaric)
Score of 16 or higher on the Center for Epidemiological Studies-Depression Scale (CES-D)
Self-reported current diagnosis of major depression
Currently taking 2 or more ant-depression drugs
History of stroke
Incarcerated individuals (i.e., Prisoners)

What this trial measures

  • Change in accelerometer-measured moderate-to-vigorous intensity physical activity from baseline to 6- and 9-monthsAssessed at baseline, 6-months, 9-months

    Participants will wear wrist-worn ActiGraph GT9X Link Activity monitors the activity monitor on their non-dominant wrist during all waking hours for 7 consecutive days to provide an assessment of usual activity.

  • Change in Fitbit-assessed moderate-to-vigorous intensity physical activityAssessed daily up to 9-months

    Participants will wear a wrist-worn Fitbit activity monitor daily throughout the 9-month intervention.

  • Change in self-reported moderate-to-vigorous intensity physical activity from baseline to 6- and 9-monthsAssessed at baseline, 6-months, 9-months

    Self-reported minutes per week of moderate-to-vigorous physical activity assessed by the 7-day Physical Activity Recall.